Cargando…
Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1
BACKGROUND: Malignant peripheral nerve sheath tumors (MPNSTs) are a serious complications of neurofibromatosis type 1 associated with poor prognosis and deeper lesions can be difficult to diagnose. 18-FDG PET improves the detection of malignancies. However, the criteria for malignancy, notably the S...
Autores principales: | Combemale, Patrick, Valeyrie-Allanore, Laurence, Giammarile, Francesco, Pinson, Stephane, Guillot, Bernard, Goulart, Denis Mariano, Wolkenstein, Pierre, Blay, Jean Yves, Mognetti, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916322/ https://www.ncbi.nlm.nih.gov/pubmed/24516522 http://dx.doi.org/10.1371/journal.pone.0085954 |
Ejemplares similares
-
Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966
por: Bergqvist, Christina, et al.
Publicado: (2020) -
Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients
por: Brahmi, Mehdi, et al.
Publicado: (2015) -
Metabolic Tumour Burden Measured by (18)F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1
por: Van Der Gucht, Axel, et al.
Publicado: (2016) -
Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review
por: Zehou, Ouidad, et al.
Publicado: (2013) -
Patch testing in drug cutaneous adverse reactions: value of the extemporaneous preparations
por: Assier, Haudrey, et al.
Publicado: (2014)